Smithfield Trust Co Purchases 267 Shares of Zoetis Inc. (NYSE:ZTS)

Smithfield Trust Co boosted its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 14.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,094 shares of the company’s stock after acquiring an additional 267 shares during the period. Smithfield Trust Co’s holdings in Zoetis were worth $410,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. Pacer Advisors Inc. raised its holdings in Zoetis by 15.4% during the 3rd quarter. Pacer Advisors Inc. now owns 46,611 shares of the company’s stock worth $9,107,000 after buying an additional 6,237 shares during the period. German American Bancorp Inc. boosted its stake in Zoetis by 10.9% in the 3rd quarter. German American Bancorp Inc. now owns 21,046 shares of the company’s stock worth $4,112,000 after purchasing an additional 2,065 shares during the period. Landscape Capital Management L.L.C. acquired a new stake in shares of Zoetis in the 3rd quarter valued at about $458,000. King Luther Capital Management Corp lifted its holdings in shares of Zoetis by 1.5% in the third quarter. King Luther Capital Management Corp now owns 1,815,949 shares of the company’s stock valued at $354,800,000 after purchasing an additional 26,918 shares in the last quarter. Finally, Altman Advisors Inc. acquired a new position in shares of Zoetis during the third quarter worth about $1,729,000. 92.80% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

ZTS has been the topic of several research reports. Piper Sandler boosted their target price on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, August 14th. Stifel Nicolaus boosted their price objective on shares of Zoetis from $200.00 to $210.00 and gave the stock a “buy” rating in a research report on Wednesday, September 18th. JPMorgan Chase & Co. increased their target price on shares of Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Argus raised shares of Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. Finally, BTIG Research increased their price objective on shares of Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, August 12th. Ten research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Zoetis currently has a consensus rating of “Buy” and an average price target of $221.44.

Zoetis Price Performance

Shares of NYSE ZTS opened at $176.71 on Friday. Zoetis Inc. has a twelve month low of $144.80 and a twelve month high of $201.92. The company has a market cap of $79.73 billion, a PE ratio of 33.22, a price-to-earnings-growth ratio of 2.69 and a beta of 0.90. The business’s 50 day moving average price is $185.90 and its two-hundred day moving average price is $180.45. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26.

Zoetis (NYSE:ZTS) last posted its quarterly earnings results on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, beating analysts’ consensus estimates of $1.46 by $0.12. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The business had revenue of $2.40 billion for the quarter, compared to analysts’ expectations of $2.29 billion. During the same quarter in the prior year, the business earned $1.36 EPS. The firm’s revenue for the quarter was up 11.6% on a year-over-year basis. On average, analysts predict that Zoetis Inc. will post 5.9 EPS for the current year.

Zoetis Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 3rd. Investors of record on Thursday, October 31st will be paid a $0.432 dividend. The ex-dividend date is Thursday, October 31st. This represents a $1.73 dividend on an annualized basis and a yield of 0.98%. Zoetis’s dividend payout ratio (DPR) is currently 32.52%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.